Angiotensin-Converting Enzyme Inhibitors After Renal Transplantation

Transplantation Proceedings

Volumn 40, Issue 3, 2008, Pages 740-742

  Bravo, P ^a   Felgueiras, J ^a   Santos, C ^a   Oliveira, C ^a   Ponce, P ^a  

^a HOSPITAL GARCIA DE ORTA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; LISINOPRIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTOSIS; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOTENSION; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEINURIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CADAVER; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; LISINOPRIL; POLYCYTHEMIA; POSTOPERATIVE COMPLICATIONS; PROTEINURIA; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 42949166363     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.014     Document Type: Article

References (15)

1. Lewis E.J., Hunsicker L.G., Bain R.P., et al., Collaborative Study Group. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 329 (1993) 1456
2. GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomized placebo-controlled trial of the effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349 (1997) 1857
3. Yusuf S., Sleight P., Pogue J., et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145
4. Fox K.M. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362 (2003) 782
5. Heinze G., Mitterbauer C., Regele H., et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17 (2006) 889
6. Artz M.A., Hilbrands L.B., Borm G., et al. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 19 (2004) 2852
7. Zaltzman J.S., Nash M., Chiu R., et al. The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy. Nephrol Dial Transplant 19 (2004) 940
8. Benediktsson H., Chea R., Davidoff A., et al. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function. Transplantation 62 (1996) 1634
9. Paul L.C., and Benediktsson H. Post-transplant hypertension and chronic renal allograft failure. Kidney Int Suppl 52 (1995) S34
10. Opelz G., Zeier M., Laux G., et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol 17 (2006) 3257
11. Stigant C.E., Cohen J., Vivera M., et al. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am J Kidney Dis 35 (2000) 58
12. Midtvedt K., Hartmann A., Holdaas H., et al. Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial. Clin Transplant 15 (2001) 426
13. Lin J., Valeri A.M., Markowitz G.S., et al. Angiotensin converting enzyme inhibition in chronic allograft nephropathy. Transplantation 73 (2002) 783
14. Tutone V.K., Mark P.B., Stewart G.A., et al. Hypertension, antihypertensive agents and outcomes following renal transplantation. Clin Transplant 19 (2005) 181
15. Heinze G., and Oberbauer R. Does size matter?. Nephrol Dial Transplant 22 (2007) 2725